Synchrony Financial, US87165B1035

Synchrony Financial Stock - Analyst consensus stays positive

18.06.2026 - 18:30:53 | ad-hoc-news.de

Synchrony Financial remains a buy-rated US card and consumer finance specialist, with a broadly positive analyst consensus. On this Thursday the focus is on the latest Wall Street targets, rating split and what that implies for the credit card stock’s risk profile.

Synchrony Financial, US87165B1035
Synchrony Financial, US87165B1035

Edited by ad hoc news Analyst & Consensus Desk. Verified prior to publication on 06/18/2026, 18:28 CET. Details in the imprint.

Synchrony Financial (US87165B1035) continues to draw broadly positive views from Wall Street. Analyst data compiled this week show a clear buy-leaning consensus on the US private-label credit card and consumer finance specialist, with targets implying meaningful upside from recent trading levels.

Go deeper

All news and analysis on Synchrony Financial stock

More figures, filings and background on Synchrony Financial stock, including past earnings, capital returns and risk disclosures, can be found in the ad hoc news topic hub and the company’s investor relations pages.

What consensus data show

According to current aggregated data, 18 analysts now cover Synchrony Financial, with a consensus recommendation of **Buy**. Around 28% of them rate the stock as Strong Buy, 39% as Buy and 33% as Hold, with no active Sell ratings reported.

On the price side, the average 12-month target stands at about $86.06 per share. That compares with a recent closing level around the mid-$70s, leaving a double-digit percentage gap that the analyst community still regards as reachable based on fundamentals.

How the stock screens today

On quantitative screens, Synchrony Financial trades on a trailing price-earnings ratio of roughly 7.6, placing it at a discount to many broader US financials. A recent snapshot put its market capitalization near $24.9 billion, underscoring its status as a mid-to-large-cap lender within the financial services space.

TradingKey data also highlight that the company sits near the top of its peer group on several factor metrics, ranking 2 out of 399 names in the broader banking services industry on one composite score. The same analysis characterizes Synchrony’s fundamentals as "relatively very healthy" with strong technical support in the current trading range.

Analyst angles this Thursday

The Thursday focus for Synchrony Financial is squarely on valuation, risk and macro sensitivity rather than on a fresh company-specific catalyst. The consensus Buy stance reflects expectations that consumer credit quality and funding costs remain manageable in a gradually normalizing rate environment.

Analyst reports in recent weeks have emphasized the combination of a robust capital position and ongoing capital returns, alongside credit metrics that, while normalizing from unusually benign levels, remain within historical bands for a cyclical issuer. Against this backdrop, investors are watching closely for any shift in guidance at upcoming results.

Position in the card and lending landscape

Within the US credit card ecosystem, Synchrony Financial competes with universal banks and other monoline card issuers, but its focus on private-label and co-branded programs creates a distinct earnings profile. This model typically pairs retailer relationships with data-based underwriting and marketing capabilities.

The stock is also part of the broader US regional and consumer finance cohort, which has been trading as a macro proxy on US employment, wage growth and household balance sheets. Synchrony’s beta to these variables means its shares tend to be more volatile than the Standard & Poor's 500 index over a full cycle.

What the company sells

Synchrony Financial generates most of its revenue by providing private-label and co-branded credit cards, installment loans and point-of-sale financing to US consumers through retail and healthcare partners. It earns interest income on loan receivables and fee income from its card programs.

Where the stock trades today

The shares of Synchrony Financial (US87165B1035) trade on the New York Stock Exchange under the ticker SYF at $74.13 as of 06/17/2026, 16:00 ET.

Key facts on Synchrony Financial stock

  • Company: Synchrony Financial Inc.
  • ISIN: US87165B1035
  • Ticker: SYF
  • Venue: NYSE
  • Price (as of 06/17/2026, 16:00 ET): 74.13 USD
  • Market cap: 24.93 billion USD (as of 06/17/2026)
  • Sector / Industry: Financials / Consumer Finance
  • Index membership: Standard & Poor's 500 index
  • Next earnings date: not officially scheduled

More on Synchrony Financial stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

en | US87165B1035 | SYNCHRONY FINANCIAL | boerse | 69574725 | bgmi